1-2 of 2
Jay Horrow, MD, MS, FAHA
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Risk Factors for Bleeding in Patients with Nonvalvular Atrial Fibrillation Who Are Receiving Anticoagulant Therapy with Ximelagatran or Warfarin: Findings from the SPORTIF III and V Trials.

James D. Douketis, MD, FRCP (C), Karin Arneklev, MSc, Samuel Goldhaber, MD, John Spandorfer, MD, Frank Halperin, MD, Jay Horrow, MD, MS, FAHA
Journal: Blood
Blood (2004) 104 (11): 528.
https://doi.org/10.1182/blood.V104.11.528.528
Published: 2004
Journal Articles

Ximelagatran Versus Warfarin: A Comparison of Bleeding Outcomes in Patients with Nonvalvular Atrial Fibrillation.

James D. Douketis, MD, FRCP(C), Karin Arneklev, MSc, Samuel Goldhaber, MD, John Spandorfer, MD, Frank Halperin, MD, Jay Horrow, MD, MS, FAHA
Journal: Blood
Blood (2004) 104 (11): 1765.
https://doi.org/10.1182/blood.V104.11.1765.1765
Published: 2004